1. Home
  2. XBIO vs GFAI Comparison

XBIO vs GFAI Comparison

Compare XBIO & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$1.66

Market Cap

4.7M

Sector

Health Care

ML Signal

N/A

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

N/A

Current Price

$0.17

Market Cap

5.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIO
GFAI
Founded
N/A
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
5.5M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
XBIO
GFAI
Price
$1.66
$0.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.3K
★ 206.3K
Earning Date
11-24-2026
09-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.52
N/A
EPS
N/A
★ N/A
Revenue
★ $2,976,411.00
N/A
Revenue This Year
$2.37
$11.88
Revenue Next Year
N/A
$5.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 19.04
N/A
52 Week Low
$1.58
$0.17
52 Week High
$4.94
$0.98

Technical Indicators

Market Signals
Indicator
XBIO
GFAI
Relative Strength Index (RSI) 35.30 34.68
Support Level $1.58 N/A
Resistance Level $3.21 $0.41
Average True Range (ATR) 0.20 0.01
MACD 0.01 0.00
Stochastic Oscillator 22.89 29.02

Price Performance

Historical Comparison
XBIO
GFAI

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific region. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, and Corporate and others. The majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions. Geographically, the company generates maximum revenue from Thailand.

Share on Social Networks: